These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10390315)
21. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. Flamm ES; Adams HP; Beck DW; Pinto RS; Marler JR; Walker MD; Godersky JC; Loftus CM; Biller J; Boarini DJ J Neurosurg; 1988 Mar; 68(3):393-400. PubMed ID: 3343611 [TBL] [Abstract][Full Text] [Related]
22. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245 [TBL] [Abstract][Full Text] [Related]
23. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Elliott JP; Newell DW; Lam DJ; Eskridge JM; Douville CM; Le Roux PD; Lewis DH; Mayberg MR; Grady MS; Winn HR J Neurosurg; 1998 Feb; 88(2):277-84. PubMed ID: 9452236 [TBL] [Abstract][Full Text] [Related]
24. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602 [TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Torner JC J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326 [TBL] [Abstract][Full Text] [Related]
26. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746 [TBL] [Abstract][Full Text] [Related]
27. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo. Fathi AR; Marbacher S; Graupner T; Wehrli F; Jakob SM; Schroth G; Fandino J Acta Neurochir (Wien); 2011 Aug; 153(8):1669-75; discussion 1675. PubMed ID: 21671141 [TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602 [TBL] [Abstract][Full Text] [Related]
29. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases. Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391 [TBL] [Abstract][Full Text] [Related]
30. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. Ohman J; Servo A; Heiskanen O J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535 [TBL] [Abstract][Full Text] [Related]
31. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related]
32. Nimodipine evoked dilation of cerebral arteries early during the development of late vasospasm in subarachnoid hemorrhage. Hillman J; Bynke O; Westergren H Neurochirurgia (Stuttg); 1991 Sep; 34(5):157-9. PubMed ID: 1745323 [TBL] [Abstract][Full Text] [Related]
33. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling. Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268 [TBL] [Abstract][Full Text] [Related]
34. A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review. Ehlert A; Manthei G; Hesselmann V; Mathias K; Bein B; Pluta R World Neurosurg; 2016 Jul; 91():673.e11-8. PubMed ID: 27109628 [TBL] [Abstract][Full Text] [Related]
35. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Philippon J; Grob R; Dagreou F; Guggiari M; Rivierez M; Viars P Acta Neurochir (Wien); 1986; 82(3-4):110-4. PubMed ID: 3538789 [TBL] [Abstract][Full Text] [Related]
36. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Yanamoto H; Kikuchi H; Sato M; Shimizu Y; Yoneda S; Okamoto S Neurosurgery; 1992 Mar; 30(3):358-63. PubMed ID: 1620298 [TBL] [Abstract][Full Text] [Related]